In a new job - November 17, 2018
New Nordic CEO of Celgene
Michaël Lugez has been appointed CEO of Celgene Nordic, replacing Nicolas Verbeke who will remain at the company as General Manager Celegne in central Europe and northern Europe. Lugez has been working at Celgene since 2014 and has most recently held a position as Head of Business Inflammation and Immunology in France. “Celgene Nordic is in […]
In a new job - November 14, 2018
New Senior Advisor Business Development at Oslo Cancer Cluster
Thomas Andersson is the new Senior Advisor for Business Development at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. Thomas holds a Ph.D. in Physical Chemistry from Lund University in Sweden and has more than 30 years of experience from establishing, operating and funding start-ups in the life science field. He has a long background in business […]
In a new job - November 14, 2018
Pharmacolog appoints new Development Manager
Pharmacolog appoints Lars Gusch as Development Manager. Lars has a long experience in product development and project management and will start his position January 1st 2019. Lars comes most recently from C-Rad AB, where he had the role of Global Service Manager. As a development manager, Lars will be responsible for our development projects together […]
In a new job - November 14, 2018
Zelluna Immunotherapy appoints new Chief Financial Officer
The company announces the appointment of Geir Christian Melen as chief financial officer (CFO). “Interest from the scientific and investor communities in Zelluna’s TCRs has increased substantially throughout 2018. As a result, Zelluna selected a CFO with the appropriate expertise to match the therapeutic potential of the company,” said Miguel Forte, CEO, Zelluna. “The strong […]
In a new job - November 14, 2018
NDA Group expands presence in Denmark
In time for the European BIO meeting in Copenhagen, NDA Group, is expanding the physical presence in Denmark with the appointment of Katja Gustafsson as Senior Consultant. The company will be working closely with clients in the region. The news follows several recent announcements of the company’s expansions in Europe and the US. Katja is […]
In a new job - October 15, 2018
Carl Borrebaeck is new member of the board at Qlucore
Carl Borrebaeck brings experience from his time as a board member of Immunovia AB, SenzaGen AB, CB Ocean Capital AB, Alligator Bioscience AB, Clinical Laserthermia Systems AB, Scandion A/S, and commercial experience from a number of IPOs. He has a DSc in biochemistry with a focus on molecular immunology, is a professor and former Vice President at […]
